Abacus FCF Small Cap Leaders ETF
ABLS
Chicago Board Options Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Abacus FCF Small Cap Leaders ETF (ABLS) is an exchange-traded fund sponsored by Abacus FCF Advisors that seeks long-term capital appreciation by investing in U.S. small-cap stocks identified through a systematic free cash flow framework focused on Free Cash Flow Return on Invested Capital (FCF-ROIC). The fund is listed on Cboe BZX Exchange, was launched on February 18, 2025, and is based in the United States; Abacus FCF Advisors presents itself as a leader in free cash flow investing and analytics and offers core and thematic free cash flow equity strategies, as well as customizable index strategies across ETFs, SMA/white label SMA, and model delivery. The fund’s portfolio construction emphasizes a select group of companies with strong cash flow fundamentals and uses a repeatable, rules-based methodology designed to identify profitable small-cap leaders. ABLS may hold operating companies and cash or cash-equivalent positions, and its published holdings have included Argan, Enova International, Oscar Health, Artisan Partners Asset Management, Collegium Pharmaceutical, Healthcare Services Group, Qualys, Progyny, and Harmony Biosciences; the fund’s expense ratio is 0.59% gross and 0.39% net, with a 0.20% fee waiver effective until July 31, 2026. The issuer reports that the portfolio is built around high-conviction ideas, disciplined risk management, and an adaptive process that reassesses FCF-ROIC leaders over time. Recent company and fund developments include the ETF’s listing on Cboe BZX in February 2025, continued portfolio and performance reporting through 2026, and updated fund materials showing net assets, premium/discount data, distributions, and quarterly performance as of mid-2026. The firm’s current public materials also highlight a broader product platform for free cash flow investing, indicating continued expansion of its strategy lineup rather than a narrow single-fund offering.